COVID-19危重症后的结局与管理
本文为综述,聚焦COVID-19危重症幸存者的结局与管理。COVID-19自2019年出现以来已在全球造成超过700万例死亡,尽管疫苗接种、新疗法和新变异株使死亡率下降,但危重症幸存者数量仍高。幸存者可遗留SARS-CoV-2病毒本身及危重症长期影响(包括重症监护后综合征)所致的后遗症,表现为ICU获得性衰弱、迁延性呼吸症状、认知改变、创伤后应激障碍、焦虑和抑郁等,且各效应间相互作用。发生危重症的危险因素复杂,包括既存因素、病程、住院具体情况以及心理共病和社会环境因素;恢复轨迹尚未明确,管理需要综合、跨学科和个体化的照护。推荐采用生物心理社会生态模型指导幸存者照护。
要点
- COVID-19危重症幸存者数量仍高,可遗留ICU获得性衰弱、迁延性呼吸症状、认知改变、创伤后应激障碍、焦虑和抑郁等后遗症。
- 发生COVID-19危重症的危险因素包括既存因素、病程、住院具体情况、心理共病和社会环境因素。
- 恢复轨迹尚未明确,管理需要综合、跨学科和个体化的照护。
- 生物心理社会生态模型整合躯体、认知、心理领域以及社会系统与环境的相互作用,可辅助幸存者的评估与治疗。
- 推荐采用生物心理社会生态方法指导COVID-19危重症幸存者的照护。
适用人群与场景
- COVID-19危重症幸存者,处于重症后恢复阶段。
处置流程与药物剂量
- 采用生物心理社会生态模型进行幸存者评估与治疗,整合躯体、认知、心理领域以及社会系统与环境的相互作用。
- 管理需要综合、跨学科和个体化的照护方法。
研究设计与关键结果
- 综述指出,COVID-19危重症后迁延性疾病一般可分为对躯体、认知和心理社会功能的影响,各效应间存在大量相互作用,症状包括ICU获得性衰弱、迁延性呼吸症状、认知改变、创伤后应激障碍、焦虑和抑郁。
- 发生COVID-19危重症的危险因素复杂,包括既存因素、病程、住院具体情况以及心理共病和社会环境因素。
- 恢复轨迹尚未明确。
- COVID-19自2019年出现以来已在全球造成超过700万例死亡;疫苗接种、新疗法和SARS-CoV-2新变异株的出现使COVID-19死亡率下降,但COVID-19危重症幸存者数量仍高。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐采用生物心理社会生态方法指导COVID-19危重症幸存者的照护,管理需综合、跨学科和个体化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
TOPIC IMPORTANCE: COVID-19 has caused > 7 million deaths worldwide since its onset in 2019. Although the severity of illness has varied throughout the pandemic, critical illness related to COVID-19 persists. Survivors of COVID-19 critical illness can be left with sequelae of both the SARS-CoV-2 virus and long-term effects of critical illness included within post-intensive care syndrome. Given the complexity and heterogeneity of COVID-19 critical illness, the biopsychosocial-ecological model can aid in evaluation and treatment of survivors, integrating interactions among physical, cognitive, and psychological domains, as well as social systems and environments.
REVIEW FINDINGS: Prolonged illness after COVID-19 critical illness generally can be classified into effects on physical, cognitive, and psychosocial function, with much interaction among the various effects, and includes a wide range of symptoms such as ICU-acquired weakness, prolonged respiratory symptoms, cognitive changes, post-traumatic stress disorder post-traumatic stress disorder, anxiety, and depression. Risk factors for COVID-19 critical illness developing are complex and include preexisting factors, disease course, and specifics of hospitalization in addition to psychological comorbidities and socioenvironmental factors. Recovery trajectories are not well defined, and management requires a comprehensive, interdisciplinary, and individualized approach to care.
SUMMARY: The onset of vaccinations, new therapeutics, and new strains of SARS-CoV-2 virus have decreased COVID-19 mortality; however, the number of survivors of COVID-19 critical illness remains high. A biopsychosocial-ecological approach is recommended to guide care of COVID-19 critical illness survivors.
参考来源
- Cagino L, Seagly K, Noyes E, et al. Outcomes and Management After COVID-19 Critical Illness. Chest. 2023. PMID: 38104961. doi:10.1016/j.chest.2023.11.044
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。